Patients were randomized to treatment with bisphosphonates ( risedronate 35 mg weekly ) for 12 months ( B ; n = 28 ) , treatment with bisphosphonates along with nutritional supplementation ( 40 g protein , 600 kcal daily ) for the first 6 months ( BN ; n = 26 ) , or to controls ( C ; n = 25 ) .